Search results
Tesla Blows Past Resistance On 'Home Run' China FSD Approval. Cathie Wood Bullish On AI Investment.
Investor's Business Daily· 15 hours agoWood has long been bullish on Tesla, believing in the long-term value of full self-driving and...
3 Value Stocks to Buy on the Dip: April 2024
InvestorPlace· 1 day agoOutside of recent rumblings, the sentiment surge in the equities space this year has taken some of the shine off value stocks to buy on the dip. Below...
Japan's currency falls to its weakest since 1990 against the dollar as the yen keeps yelping
Quartz· 18 hours agoThe value of Japan’s currency has tumbled so much that for a moment on Monday it took 160 yen to...
Beijing Auto Show Is a Home Run, but Mostly for Domestic Brands
Car and Driver via AOL· 5 days agoXiaomi SU7.Tom Salt - Car and Driver Ventures Almost all fresh products on display in the...
Eastern Europe Is Richer Than Ever — And More Divided
Bloomberg via Yahoo Finance· 7 hours agoIncreasingly, Only 10 MatterUS Warns ICC Acti
Trending tickers: Tesla, Hipgnosis, oil, yen
Yahoo Finance UK· 1 day agoHipgnosis's offering will add more than 65,000 songs to that roster. Tesla (TSLA) Tesla stock was up nearly 5% in premarket trade on Monday, having...
They bought Nvidia stock before the hype. It's paid for cars, vacations, and a deposit on a dream...
Business Insider via Yahoo Finance· 5 days ago"And so $600 turned into $140K," Rick said. With Nvidia, Rick said he felt he had a safety net to...
Samsung says Q1 operating profits soar nearly tenfold on-year
AFP via Yahoo Finance· 8 hours agoSamsung Electronics said Tuesday that its first-quarter operating profits had risen nearly tenfold...
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Zacks via Yahoo Finance· 7 days agoAchieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that...
Poolbeg Pharma PLC Announces Results for the Year Ended 31 December 2023
Digital Journal· 3 hours agoWith a market opportunity exceeding US$10 billion in cancer immunotherapy-induced CRS, positive data generated, and a robust patent portfolio - POLB 001 has great potential to generate significant ...
